Risk factor
Negligible price volatility
Profitability factor
Slightly undervalued vs peers
About
Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. It offers various pharmaceutical products to treat glaucoma and ocular hypertension, such as DE-111, which is in Phase III clinical trial; DE-117 in Japan; DE-126 that is in Phase IIb clinical trial; DE-128 in Europe, as well...
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral o
Target Price
The average target price of 4536.T is 2100 and suggests 22% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell